Esa Jantunen

3.3k total citations
73 papers, 2.0k citations indexed

About

Esa Jantunen is a scholar working on Oncology, Epidemiology and Hematology. According to data from OpenAlex, Esa Jantunen has authored 73 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 22 papers in Epidemiology and 18 papers in Hematology. Recurrent topics in Esa Jantunen's work include Neutropenia and Cancer Infections (22 papers), Lymphoma Diagnosis and Treatment (17 papers) and Sepsis Diagnosis and Treatment (13 papers). Esa Jantunen is often cited by papers focused on Neutropenia and Cancer Infections (22 papers), Lymphoma Diagnosis and Treatment (17 papers) and Sepsis Diagnosis and Treatment (13 papers). Esa Jantunen collaborates with scholars based in Finland, Spain and France. Esa Jantunen's co-authors include T. Nousiainen, Liisa Volin, Petri Ruutu, T Parkkali, Outi Kuittinen, Tapani Ruutu, Irma Koivula, Pirkko Koukila-Kähkölä, Tapio Nousiainen and Sari Hämäläinen and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Scientific Reports.

In The Last Decade

Esa Jantunen

71 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esa Jantunen Finland 23 861 663 569 343 322 73 2.0k
Albert K. W. Lie China 23 993 1.2× 887 1.3× 666 1.2× 241 0.7× 493 1.5× 59 2.3k
Aks Chiang Hong Kong 35 1.7k 2.0× 1.1k 1.6× 652 1.1× 466 1.4× 833 2.6× 121 3.0k
Patrick Lutz France 26 490 0.6× 354 0.5× 477 0.8× 372 1.1× 326 1.0× 62 2.3k
Isidro Jarque Spain 27 661 0.8× 438 0.7× 739 1.3× 461 1.3× 388 1.2× 156 2.6k
Anne Parker United Kingdom 23 1.1k 1.3× 768 1.2× 460 0.8× 195 0.6× 567 1.8× 54 2.6k
Edward W. Cowen United States 31 567 0.7× 374 0.6× 587 1.0× 264 0.8× 852 2.6× 155 3.2k
Gunjan L. Shah United States 24 1.1k 1.3× 282 0.4× 215 0.4× 301 0.9× 261 0.8× 188 1.9k
Kathleen M. Wyvill United States 28 1.7k 2.0× 818 1.2× 727 1.3× 785 2.3× 420 1.3× 57 2.8k
B. Crickx France 28 535 0.6× 646 1.0× 874 1.5× 136 0.4× 371 1.2× 118 3.1k
T.R. Hakala United States 18 1.1k 1.3× 440 0.7× 639 1.1× 324 0.9× 202 0.6× 53 2.3k

Countries citing papers authored by Esa Jantunen

Since Specialization
Citations

This map shows the geographic impact of Esa Jantunen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esa Jantunen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esa Jantunen more than expected).

Fields of papers citing papers by Esa Jantunen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esa Jantunen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esa Jantunen. The network helps show where Esa Jantunen may publish in the future.

Co-authorship network of co-authors of Esa Jantunen

This figure shows the co-authorship network connecting the top 25 collaborators of Esa Jantunen. A scholar is included among the top collaborators of Esa Jantunen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esa Jantunen. Esa Jantunen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Partanen, Anu, Outi Kuittinen, Hanne Kuitunen, et al.. (2024). Predictive Factors for Early Immune Recovery in NHL Patients after Autologous Transplantation: A Multicenter Prospective Study. Cancers. 16(14). 2550–2550. 3 indexed citations
2.
Sorigué, Marc, Madiha Khan, Esa Jantunen, et al.. (2024). Front‐line and second‐line treatment for mantle cell lymphoma in clinical practice: A multicenter retrospective analysis. European Journal Of Haematology. 113(2). 218–226.
3.
Hämäläinen, Sari, et al.. (2021). Serum caspase-cleaved cytokeratin-18 fragment as a prognostic biomarker in hematological patients with febrile neutropenia. Clinical and Experimental Medicine. 22(1). 83–93. 5 indexed citations
4.
Arvonen, Miika, Sari Hämäläinen, Esa Jantunen, et al.. (2019). MMP-10 and TIMP-1 as indicators of severe sepsis in adult hematological patients with febrile neutropenia. Leukemia & lymphoma. 60(12). 3036–3043. 5 indexed citations
5.
Hämäläinen, Sari, et al.. (2017). Soluble CD14 as a Diagnostic and Prognostic Biomarker in Hematological Patients with Febrile Neutropenia. Disease Markers. 2017. 1–8. 14 indexed citations
6.
Haapasaari, Kirsi‐Maria, Taina Turpeenniemi‐Hujanen, Esa Jantunen, et al.. (2015). High intensity of cytoplasmic peroxiredoxin VI expression is associated with adverse outcome in diffuse large B-cell lymphoma independently of International Prognostic Index. Journal of Clinical Pathology. 68(7). 552–556. 7 indexed citations
7.
Jantunen, Esa & Ville Varmavuo. (2014). Plerixafor for mobilization of blood stem cells in autologous transplantation: an update. Expert Opinion on Biological Therapy. 14(6). 851–861. 13 indexed citations
8.
d’Amore, Francesco, Thomas Relander, Grete F. Lauritzsen, et al.. (2012). Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01. Journal of Clinical Oncology. 30(25). 3093–3099. 386 indexed citations
9.
Matinlauri, Irma, Auni Juutilainen, Sari Hämäläinen, et al.. (2010). Fibrinogen and antithrombin in hematological patients with neutropenic fever. Open Medicine. 5(4). 520–526. 2 indexed citations
10.
Hämäläinen, Sari, Taru Kuittinen, Irma Matinlauri, et al.. (2008). Severe sepsis in autologous stem cell transplant recipients: Microbiological aetiology, risk factors and outcome. Scandinavian Journal of Infectious Diseases. 41(1). 14–20. 30 indexed citations
11.
Räty, Riikka, Sakari Knuutila, Kim Vettenranta, et al.. (2008). Acute lymphoblastic leukemia in adolescents and young adults in Finland. Haematologica. 93(8). 1161–1168. 75 indexed citations
12.
Jantunen, Esa, Anne Nihtinen, & Veli‐Jukka Anttila. (2008). Changing landscape of invasive aspergillosis in allogeneic stem cell transplant recipients. Transplant Infectious Disease. 10(3). 156–161. 14 indexed citations
13.
Hämäläinen, Sari, Taru Kuittinen, Irma Matinlauri, et al.. (2008). Neutropenic fever and severe sepsis in adult acute myeloid leukemia (AML) patients receiving intensive chemotherapy: Causes and consequences. Leukemia & lymphoma. 49(3). 495–501. 60 indexed citations
14.
Jantunen, Esa, et al.. (2004). Candidaemia in allogeneic stem cell transplant recipients: low risk without fluconazole prophylaxis. Bone Marrow Transplantation. 34(10). 891–895. 19 indexed citations
15.
16.
Nousiainen, T., Esa Jantunen, Esko Vanninen, & Juha Hartikainen. (2002). Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients. British Journal of Cancer. 86(11). 1697–1700. 125 indexed citations
17.
Jantunen, Esa. (2002). Bisphosphonate therapy in multiple myeloma: past, present, future. European Journal Of Haematology. 69(5-6). 257–264. 22 indexed citations
18.
Jantunen, Esa & R Myllykangas-Luosujärvi. (2000). Stem cell transplantation for treatment of severe autoimmune diseases: current status and future perspectives. Bone Marrow Transplantation. 25(4). 351–356. 13 indexed citations
19.
Jantunen, Esa, Petri Ruutu, Anneli Piilonen, et al.. (2000). Treatment and outcome of invasive Aspergillus infections in allogeneic BMT recipients. Bone Marrow Transplantation. 26(7). 759–762. 46 indexed citations
20.
Jantunen, Esa, Elina Kolho, Petri Ruutu, et al.. (1996). Invasive cutaneous mucormycosis caused by Absidia corymbifera after allogeneic bone marrow transplantation.. PubMed. 18(1). 229–30. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Albert K. W. Lie Breakdown of academic impact, for papers by Aks Chiang Breakdown of academic impact, for papers by Patrick Lutz Breakdown of academic impact, for papers by Isidro Jarque Breakdown of academic impact, for papers by Anne Parker Breakdown of academic impact, for papers by Edward W. Cowen Breakdown of academic impact, for papers by Gunjan L. Shah Breakdown of academic impact, for papers by Kathleen M. Wyvill Breakdown of academic impact, for papers by B. Crickx Breakdown of academic impact, for papers by T.R. Hakala
Rankless by CCL
2026